12.15.25 -- New Initiative Helps Researchers Enroll Healthy Volunteers In High Impact

Explore how to design ethical, effective, and patient-centric AI-powered recruitment pipelines that truly connect the right patients to the right trials.

Digital clinical trial recruitment is revolutionizing patient engagement. Discover how cutting-edge technologies are reshaping recruitment strategies and transforming the future of global healthcare.

Recruiting the right patients into a clinical trial is only half the battle. To combat attrition, sponsors must also institute measures that ensure patients remain comfortable and confident throughout the trial.

Are you considering new options to improve your patient experience and expand your clinical trial's reach? Mobile vision clinics provide a full optometry suite for all types of clinical trials.

Address critical challenges with patient enrollment, including difficulties in identifying eligible participants which often leads to delays and increased costs.

With dedicated CTA Negotiation, Site Payment, and Financial Analysis experts, we reduce site burden and optimize study execution so your team can focus on delivering exceptional research as care.

For clinical trial technology vendors, it's fast and easy to become part of the only industry-wide solution to sit tech overload.

See how the Patient Experience Organization (PXO) model embeds patient experience at the heart of clinical development, bridging the gap between outreach and outcomes.

This roundtable brought together several experts to discuss how expanding community-based research can transform clinical trial recruitment and representation.

In part three of this series, we delve into the tax component of trial payments: what is taxed, how can you minimize tax exposure, and why this matters for recruitment and retention.

Trauma shapes how families engage with clinical trials, influencing adherence, decision-making, and data quality. Explore how a patient-centered, empathetic approach is essential to build trust.